CA2471757A1 - Biomateriaux constitues d'elastine ou a base d'elastine et procede associe - Google Patents

Biomateriaux constitues d'elastine ou a base d'elastine et procede associe Download PDF

Info

Publication number: CA2471757A1
Authority: CA; Canada
Prior art keywords: elastin; biomaterial; layer; support member; tissue
Prior art date: 1994-11-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002471757A

Other languages

English (en)

Inventor

John Grunkemeier

Kenton W. Gregory

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Providence Health System Oregon

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-15

Filing date

1995-04-04

Publication date

1996-05-23

1994-11-15 Priority claimed from US08/341,881 external-priority patent/US5989244A/en

1995-04-04 Application filed by Individual filed Critical Individual

1996-05-23 Publication of CA2471757A1 publication Critical patent/CA2471757A1/fr

Status Abandoned legal-status Critical Current

Links

102000016942 Elastin Human genes 0.000 title claims abstract description 164
108010014258 Elastin Proteins 0.000 title claims abstract description 164
229920002549 elastin Polymers 0.000 title claims abstract description 162
239000012620 biological material Substances 0.000 title claims abstract description 132
238000000034 method Methods 0.000 title claims abstract description 62
230000008569 process Effects 0.000 title claims description 28
229940079593 drug Drugs 0.000 claims description 16
239000003814 drug Substances 0.000 claims description 16
229920000642 polymer Polymers 0.000 claims description 16
229910052751 metal Inorganic materials 0.000 claims description 13
239000002184 metal Substances 0.000 claims description 13
230000005855 radiation Effects 0.000 claims description 7
238000000465 moulding Methods 0.000 claims description 6
239000011248 coating agent Substances 0.000 claims description 5
238000000576 coating method Methods 0.000 claims description 5
238000006116 polymerization reaction Methods 0.000 claims description 5
230000009885 systemic effect Effects 0.000 claims description 4
HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 3
229910001000 nickel titanium Inorganic materials 0.000 claims description 3
238000004132 cross linking Methods 0.000 claims 4
230000003247 decreasing effect Effects 0.000 claims 3
238000001990 intravenous administration Methods 0.000 claims 3
229940126701 oral medication Drugs 0.000 claims 3
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims 2
239000003431 cross linking reagent Substances 0.000 claims 2
229910001220 stainless steel Inorganic materials 0.000 claims 2
239000010935 stainless steel Substances 0.000 claims 2
229910052715 tantalum Inorganic materials 0.000 claims 2
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims 2
239000010936 titanium Substances 0.000 claims 2
229910052719 titanium Inorganic materials 0.000 claims 2
230000000694 effects Effects 0.000 abstract description 7
230000017423 tissue regeneration Effects 0.000 abstract description 6
210000001519 tissue Anatomy 0.000 description 46
239000000463 material Substances 0.000 description 34
239000000975 dye Substances 0.000 description 30
210000000709 aorta Anatomy 0.000 description 28
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 16
108090000190 Thrombin Proteins 0.000 description 15
239000011358 absorbing material Substances 0.000 description 15
229940012952 fibrinogen Drugs 0.000 description 15
229960004072 thrombin Drugs 0.000 description 15
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
102000008946 Fibrinogen Human genes 0.000 description 14
108010049003 Fibrinogen Proteins 0.000 description 14
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
230000002792 vascular Effects 0.000 description 14
239000008363 phosphate buffer Substances 0.000 description 13
238000003466 welding Methods 0.000 description 12
239000000872 buffer Substances 0.000 description 11
239000000203 mixture Substances 0.000 description 11
230000008439 repair process Effects 0.000 description 10
210000001367 artery Anatomy 0.000 description 9
239000000835 fiber Substances 0.000 description 9
239000011521 glass Substances 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
108010091326 Cryoglobulins Proteins 0.000 description 8
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
229950003499 fibrin Drugs 0.000 description 8
241000283690 Bos taurus Species 0.000 description 7
108010035532 Collagen Proteins 0.000 description 7
102000008186 Collagen Human genes 0.000 description 7
102000012422 Collagen Type I Human genes 0.000 description 7
108010022452 Collagen Type I Proteins 0.000 description 7
102000009123 Fibrin Human genes 0.000 description 7
108010073385 Fibrin Proteins 0.000 description 7
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 7
229920001436 collagen Polymers 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
239000004372 Polyvinyl alcohol Substances 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical group [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 6
229960004657 indocyanine green Drugs 0.000 description 6
208000014674 injury Diseases 0.000 description 6
239000011159 matrix material Substances 0.000 description 6
229920002635 polyurethane Polymers 0.000 description 6
239000004814 polyurethane Substances 0.000 description 6
229920002451 polyvinyl alcohol Polymers 0.000 description 6
102000004169 proteins and genes Human genes 0.000 description 6
108090000623 proteins and genes Proteins 0.000 description 6
239000000758 substrate Substances 0.000 description 6
238000001356 surgical procedure Methods 0.000 description 6
208000027418 Wounds and injury Diseases 0.000 description 5
238000002835 absorbance Methods 0.000 description 5
230000006378 damage Effects 0.000 description 5
230000029087 digestion Effects 0.000 description 5
229920005615 natural polymer Polymers 0.000 description 5
239000000843 powder Substances 0.000 description 5
102000004196 processed proteins & peptides Human genes 0.000 description 5
108090000765 processed proteins & peptides Proteins 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
108010039627 Aprotinin Proteins 0.000 description 4
102100037362 Fibronectin Human genes 0.000 description 4
108010067306 Fibronectins Proteins 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
239000002253 acid Substances 0.000 description 4
229960004405 aprotinin Drugs 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000015271 coagulation Effects 0.000 description 4
238000005345 coagulation Methods 0.000 description 4
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 4
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
210000003491 skin Anatomy 0.000 description 4
239000007858 starting material Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
208000017897 Carcinoma of esophagus Diseases 0.000 description 3
229920004934 Dacron® Polymers 0.000 description 3
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
206010030155 Oesophageal carcinoma Diseases 0.000 description 3
229920002125 Sokalan® Polymers 0.000 description 3
241000282898 Sus scrofa Species 0.000 description 3
239000004809 Teflon Substances 0.000 description 3
229920006362 Teflon® Polymers 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000001715 carotid artery Anatomy 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
238000002512 chemotherapy Methods 0.000 description 3
210000001072 colon Anatomy 0.000 description 3
239000008367 deionised water Substances 0.000 description 3
230000003511 endothelial effect Effects 0.000 description 3
201000005619 esophageal carcinoma Diseases 0.000 description 3
210000003238 esophagus Anatomy 0.000 description 3
230000004927 fusion Effects 0.000 description 3
210000003709 heart valve Anatomy 0.000 description 3
229960002897 heparin Drugs 0.000 description 3
229920000669 heparin Polymers 0.000 description 3
238000002513 implantation Methods 0.000 description 3
230000000968 intestinal effect Effects 0.000 description 3
210000004072 lung Anatomy 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
239000013307 optical fiber Substances 0.000 description 3
239000004584 polyacrylic acid Substances 0.000 description 3
229920000139 polyethylene terephthalate Polymers 0.000 description 3
239000005020 polyethylene terephthalate Substances 0.000 description 3
239000010453 quartz Substances 0.000 description 3
210000002460 smooth muscle Anatomy 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
229910000679 solder Inorganic materials 0.000 description 3
239000000725 suspension Substances 0.000 description 3
210000002435 tendon Anatomy 0.000 description 3
238000011282 treatment Methods 0.000 description 3
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
206010002329 Aneurysm Diseases 0.000 description 2
206010003210 Arteriosclerosis Diseases 0.000 description 2
102000004506 Blood Proteins Human genes 0.000 description 2
108010017384 Blood Proteins Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
102000007625 Hirudins Human genes 0.000 description 2
108010007267 Hirudins Proteins 0.000 description 2
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
208000031481 Pathologic Constriction Diseases 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
208000007536 Thrombosis Diseases 0.000 description 2
239000006096 absorbing agent Substances 0.000 description 2
FTWRSWRBSVXQPI-UHFFFAOYSA-N alumanylidynearsane;gallanylidynearsane Chemical compound [As]#[Al].[As]#[Ga] FTWRSWRBSVXQPI-UHFFFAOYSA-N 0.000 description 2
238000002399 angioplasty Methods 0.000 description 2
229940127218 antiplatelet drug Drugs 0.000 description 2
229910021641 deionized water Inorganic materials 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
-1 dieahylether Chemical compound 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000003925 fat Substances 0.000 description 2
235000019253 formic acid Nutrition 0.000 description 2
239000012634 fragment Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
229940006607 hirudin Drugs 0.000 description 2
WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 2
238000011534 incubation Methods 0.000 description 2
210000000936 intestine Anatomy 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
239000002245 particle Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
239000000106 platelet aggregation inhibitor Substances 0.000 description 2
229920000098 polyolefin Polymers 0.000 description 2
239000000047 product Substances 0.000 description 2
210000004927 skin cell Anatomy 0.000 description 2
210000000329 smooth muscle myocyte Anatomy 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
238000005476 soldering Methods 0.000 description 2
238000003756 stirring Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
230000002885 thrombogenetic effect Effects 0.000 description 2
230000008733 trauma Effects 0.000 description 2
210000000626 ureter Anatomy 0.000 description 2
229940124549 vasodilator Drugs 0.000 description 2
239000003071 vasodilator agent Substances 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
102000001187 Collagen Type III Human genes 0.000 description 1
108010069502 Collagen Type III Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
208000018672 Dilatation Diseases 0.000 description 1
206010063655 Erosive oesophagitis Diseases 0.000 description 1
108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
206010016717 Fistula Diseases 0.000 description 1
229910001218 Gallium arsenide Inorganic materials 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
208000023329 Gun shot wound Diseases 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
208000034693 Laceration Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
101100309487 Mus musculus Samhd1 gene Proteins 0.000 description 1
101100369237 Mus musculus Tgtp1 gene Proteins 0.000 description 1
101100369238 Mus musculus Tgtp2 gene Proteins 0.000 description 1
DPUYCSDGMSDKKV-MKBYFEBXSA-N N-Acetyl-L-leucyl-L-isoleucylglycyl-L-valyl-N-methyl-L-prolinamide Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC DPUYCSDGMSDKKV-MKBYFEBXSA-N 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
101100208473 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) lcm-2 gene Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108010031318 Vitronectin Proteins 0.000 description 1
102100035140 Vitronectin Human genes 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000002223 abdominal aortic aneurysm Diseases 0.000 description 1
230000003187 abdominal effect Effects 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical compound CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
235000015107 ale Nutrition 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
229940030225 antihemorrhagics Drugs 0.000 description 1
210000002403 aortic endothelial cell Anatomy 0.000 description 1
238000013459 approach Methods 0.000 description 1
208000011775 arteriosclerosis disease Diseases 0.000 description 1
230000003143 atherosclerotic effect Effects 0.000 description 1
230000001746 atrial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
210000005242 cardiac chamber Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000005253 cladding Methods 0.000 description 1
239000000701 coagulant Substances 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000001816 cooling Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
229940124568 digestive agent Drugs 0.000 description 1
230000001079 digestive effect Effects 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
238000013171 endarterectomy Methods 0.000 description 1
210000002889 endothelial cell Anatomy 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000001105 femoral artery Anatomy 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
230000003890 fistula Effects 0.000 description 1
239000005350 fused silica glass Substances 0.000 description 1
208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
210000003736 gastrointestinal content Anatomy 0.000 description 1
239000001046 green dye Substances 0.000 description 1
239000002874 hemostatic agent Substances 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
230000003902 lesion Effects 0.000 description 1
210000003041 ligament Anatomy 0.000 description 1
230000031700 light absorption Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000007443 liposuction Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
239000012778 molding material Substances 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
230000024353 muscle cell migration Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
206010034674 peritonitis Diseases 0.000 description 1
210000003800 pharynx Anatomy 0.000 description 1
230000002165 photosensitisation Effects 0.000 description 1
239000003504 photosensitizing agent Substances 0.000 description 1
OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
208000037803 restenosis Diseases 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000001878 scanning electron micrograph Methods 0.000 description 1
239000000565 sealant Substances 0.000 description 1
230000035939 shock Effects 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000036262 stenosis Effects 0.000 description 1
208000037804 stenosis Diseases 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
210000003954 umbilical cord Anatomy 0.000 description 1
210000003708 urethra Anatomy 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
108010047303 von Willebrand Factor Proteins 0.000 description 1
102100036537 von Willebrand factor Human genes 0.000 description 1
229960001134 von willebrand factor Drugs 0.000 description 1

Landscapes

Materials For Medical Uses (AREA)

CA002471757A 1994-11-15 1995-04-04 Biomateriaux constitues d'elastine ou a base d'elastine et procede associe Abandoned CA2471757A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/341,881		1994-11-15
US08/341,881 US5989244A (en)	1994-11-15	1994-11-15	Method of use of a sheet of elastin or elastin-based material
CA002205038A CA2205038C (fr)	1994-11-15	1995-04-04	Biomateriaux constitues d'elastine ou a base d'elastine et procede associe

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002205038A Division CA2205038C (fr)	1994-11-15	1995-04-04	Biomateriaux constitues d'elastine ou a base d'elastine et procede associe

Publications (1)

Publication Number	Publication Date
CA2471757A1 true CA2471757A1 (fr)	1996-05-23

Family

ID=32870043

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002471757A Abandoned CA2471757A1 (fr)	1994-11-15	1995-04-04	Biomateriaux constitues d'elastine ou a base d'elastine et procede associe

Country Status (1)

Country	Link
CA (1)	CA2471757A1 (fr)

1995
- 1995-04-04 CA CA002471757A patent/CA2471757A1/fr not_active Abandoned

Legal Events

Date	Code	Title	Description
2004-07-14	EEER	Examination request
2008-12-04	FZDE	Dead

Publication	Publication Date	Title
EP0792125B1 (fr)	2004-11-24	Biomateriaux constitues d'elastine ou a base d'elastine et procede associe
US6087552A (en)	2000-07-11	Method of producing fused biomaterials and tissue
US6110212A (en)	2000-08-29	Elastin and elastin-based materials
EP1049482B1 (fr)	2006-03-01	Procede de production d'elastine, de materiaux a base d'elastine et de materiaux a base de tropoelastine
US7001328B1 (en)	2006-02-21	Method for using tropoelastin and for producing tropoelastin biomaterials
CA2383539C (fr)	2007-12-04	Procedes de production d'elastine stratifiee, materiaux a base d'elastine et produits a base de tropoelastine permettant de reparer et/ou de remplacer des tissus
AU737125B2 (en)	2001-08-09	Method for using tropoelastin and for producing tropoelastin biomaterials
AU748911B2 (en)	2002-06-13	Method of producing biomaterials
AU746813B2 (en)	2002-05-02	Prosthetic device and process of production
AU767057B2 (en)	2003-10-30	Method of producing biomaterials
CA2471757A1 (fr)	1996-05-23	Biomateriaux constitues d'elastine ou a base d'elastine et procede associe
KR100271014B1 (ko)	2000-10-16	엘라스틴 또는 엘라스틴-기초 생체 적합 물질을 이용한 인공 보철물 장치 및 그의 제조 방법
MXPA97003589A (en)	1998-11-09	Elastina, biomaterials based on elastin and process for your producc
MXPA00006485A (en)	2002-06-05	Method of producing elastin, elastin-based biomaterials and tropoelastin materials